Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study.

Drugs Real World Outcomes · 2020 · PMC7392967 · PMID 32144746

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

32.5% for oral treprostinil and selexipag, respectively; p = 0.023) and a nonsignificant trend toward more renal disease and AIDS/HIV in the oral treprostinil cohort.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.